Nicotine Spray + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Jan 31, 2015 → Feb 10, 2016
NCT ID
NCT02355665About Nicotine Spray + Placebo
Nicotine Spray + Placebo is a phase 3 stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT02355665. Target conditions include Tobacco Dependence.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02355665 | Phase 3 | Completed |
Competing Products
20 competing products in Tobacco Dependence